- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05293587
Physical Activity to Reduce Diabetes Risk in Serious Mental Illness (PARCS Pilot)
January 30, 2023 updated by: Catherine Davis, Augusta University
Physical Activity to Reduce Diabetes Risk in Serious Mental Illness: PARCS Pilot Study
The aim of this project is to trial the protocol of a park-based physical activity (PA) intervention in adults with severe mental illness (SMI) in a community mental health center's peer support program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Aim 1: Test the feasibility and acceptability of a park-based PA intervention led by Certified Peer Specialists (CPS) and adapted for adults with SMI.
Rationale: Park-based interventions led by CPSs represent a novel approach to increase program satisfaction and adherence to PA behavior change in persons with SMI.
Hypothesis 1A: Most (80%) people offered the intervention will participate most of the time (≥2 day/week).
Hypothesis 1B: CPSs and SMI patients will express satisfaction with the program (6 on an 8-point scale).
Aim 2: Test the effectiveness of a park-based PA intervention led by CPSs on increasing PA and improving fitness in adults with SMI.
Rationale: Park-based PA is associated with greater intensity and duration of PA, better fitness, and less obesity and depression, issues that are especially problematic for adults with SMI.
Hypothesis 2A: People enrolled in the intervention will engage in more PA than at baseline (90min moderate to vigorous PA (MVPA)/week).
Hypothesis 2B: The intervention will result in improved fitness (6 min walk test) relative to baseline.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Augusta, Georgia, United States, 30912
- Georgia Prevention Institute
-
Augusta, Georgia, United States, 30906
- Serenity Behavioral Health System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Authorized for peer group treatment through the Serenity behavioral health facility
- Medically cleared for participation
- Able to act as their own legal guardian
Exclusion Criteria:
- Age under 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physical Activity
Physical activity sessions at public parks led by a Serenity Behavioral Health Certified Peer Specialist
|
Physical activity sessions will take place 3x/week over six weeks and will take between 45 and 60 minutes for each session.
The sessions will be led by a Serenity Behavioral Health CPS as part of the PEERS program and will be supervised by research staff.
Sessions will occur at public parks.
Transportation to the park will be provided by Serenity Behavioral Health.
Structured activities will include a warm-up, a mix of simple exercises requiring minimal supplies (such as walking, basic aerobic movements, and body weight resistance exercises), and cool-down.
Sessions will be held in green park environments with shade, restrooms, and level walking paths.
Other Names:
|
|
No Intervention: Waitlist
Participants will continue their usual care in the PEERS program.
They will be offered the intervention after they have completed posttest measures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent attendance
Time Frame: During 6-week intervention period
|
Feasibility will be assessed by attendance to park PA sessions (0-100%).
Higher attendance indicates greater engagement with the intervention.
|
During 6-week intervention period
|
|
Participant satisfaction
Time Frame: 8 weeks
|
Acceptability will be assessed via participant satisfaction, measured using an abbreviated version of the Physical Activity Class Satisfaction Questionnaire (PACSQ).
PACSQ is a valid measure for capturing client satisfaction within exercise classes in the following nine dimensions: mastery experiences, cognitive development, teaching, normative success, interaction with others, fun and enjoyment, improvement of health and fitness, diversionary experiences, and relaxation.
Each of the dimensions of satisfaction is measured using an 8-point Likert scale, with responses ranging from 1="No satisfaction" to 8="Very satisfying".
PACSQ has shown acceptable reliability in each of its subscales (all α's ≥ .85),
and survey items are highly correlated with participants' intentions to attend a similar course in the future.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Physical Activity
Time Frame: Baseline, during 6-week intervention period
|
Fitbit min/week moderate to vigorous physical activity.
Greater min/week physical activity is better.
|
Baseline, during 6-week intervention period
|
|
Change in Aerobic Fitness from Baseline at 8 weeks
Time Frame: Baseline, 8 weeks
|
6-minute walk test.
Greater distance indicates better fitness.
|
Baseline, 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Structured Assessment of FEeasibility
Time Frame: Approximately 1 year
|
The Structured Assessment of FEeasibility (SAFE) standardized measure will be used to determine overall intervention feasibility.
The SAFE measure specifically evaluates interventions within a mental health services framework and includes 16 items that capture information in three categories: intervention, resource consequences, and evaluation.
The PI in collaboration with CPSs will complete the SAFE measure.
The SAFE measure has demonstrated excellent inter-rater and test-retest reliability (0.84, 95% confidence interval (CI) 0.79-0.89;
0.89, 95% CI 0.85-0.93
respectively).
Rather than using a summary score, the individual items should be considered (e.g., yes, partial, no, unable to rate).
|
Approximately 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Catherine L Davis, PhD, Augusta University
- Principal Investigator: Gina M Besenyi, MPH PhD, Kansas State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 13, 2021
Primary Completion (Actual)
August 26, 2022
Study Completion (Actual)
August 31, 2022
Study Registration Dates
First Submitted
August 18, 2021
First Submitted That Met QC Criteria
March 19, 2022
First Posted (Actual)
March 24, 2022
Study Record Updates
Last Update Posted (Actual)
February 1, 2023
Last Update Submitted That Met QC Criteria
January 30, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1434186
- 3P30DK020593-42S1 (U.S. NIH Grant/Contract)
- VUMC86160 (Other Grant/Funding Number: Vanderbilt Diabetes Res. & Trng Ctr Pilot/Feasibility Grant)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Deidentified data will be shared with colleagues who have a reasonable request and analysis plan with appropriate credit.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders, Severe
-
Alejando Vargas RubioActive, not recruitingSevere Mental Disorder | Severe Mental IllnessSpain
-
University of KwaZuluColumbia University; Medical Research Council, South Africa; Universiteit AntwerpenRecruitingMental Disorders, SevereSouth Africa
-
University Hospital, ToursNot yet recruiting
-
Alejando Vargas RubioCompletedSevere Mental Disorder | Severe Mental IllnessSpain
-
IRCCS Centro San Giovanni di Dio FatebenefratelliRecruitingSevere Mental Disorder | Severe Mental IllnessItaly
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...CompletedMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Onze...RecruitingMental Disorders, SevereNetherlands
Clinical Trials on Physical Activity
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
Cardenal Herrera UniversityCompleted
-
Istituti Clinici Scientifici Maugeri SpACompleted
-
University of NottinghamBiotechnology and Biological Sciences Research CouncilRecruitingMetabolic Syndrome | Sedentary Behavior | Age-related Cognitive Decline | Age-Related SarcopeniaUnited Kingdom
-
Upper Alsace UniversityUniversity Hospital, Strasbourg, France; Centre Hospitalier Universitaire de... and other collaboratorsRecruitingQuality of Life | EndometriosisFrance
-
Assaf-Harofeh Medical CenterBen-Gurion University of the NegevUnknown